Just an observation re Bio's. Bleedingly early investors seem to...

Just an observation re Bio's.
Bleedingly early investors seem to get a nice kick when the company becomes first known and the story gets out there. In the middile (ie before P3), investors seem to get diddled with Capital raises, managment changes and all sorts of machinations in between. This is just a gut feel but either Phase 3 (on the pre registation Dip) or post on the post registration Dip (ie the reality that even though you get the registraiton you then need to ramp up sales takes some time to generate profits). Look at CUV ... It is still half of the approval high of $42.50 in September 2021....

In relation to PAR, we are not going anywhere anytime soon without a partnership deal or the P3 results. the good news is there for all to see but only the true believers believe....

Mozz dont forget we are meeting tomorrow to continue building our doomsday shelter the end is in sight ... see you at 4pm..

the Pool